Sarah Cannon and HCA Research Institute Site Number : 007 — Nashville, Tennessee

Sarah Cannon and HCA Research Institute Site Number : 007 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon and HCA Research Institute Site Number : 007 has participated in 1 clinical trials.

Therapeutic areas: Chronic Graft-versus-host-disease.

Sponsors: Kadmon, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon and HCA Research Institute Site Number : 007?

Sarah Cannon and HCA Research Institute Site Number : 007 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon and HCA Research Institute Site Number : 007 conducted?

Sarah Cannon and HCA Research Institute Site Number : 007 has 1 clinical trials on record. Their work covers Chronic Graft-versus-host-disease.

Is Sarah Cannon and HCA Research Institute Site Number : 007 accredited by Crixeo Health?

Sarah Cannon and HCA Research Institute Site Number : 007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon and HCA Research Institute Site Number : 007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.